MDS Virtual Congress 2021 » Parkinson's Disease: Neuroimaging

Meeting: MDS Virtual Congress 2021

A combined imaging based biomarker for Parkinson’s disease using diffusion kurtosis and quantitative susceptibility mapping

T. Welton, S. Hartono, S. Tan, YC. Shih, W. Lee, S. Chong, S. Ng, N. Chia, EK. Tan, L. Tan, LL. Chan (Singapore, Singapore)

A DIFFERENT RADIOLOGICAL PERSPECTIVE ON PARKINSON’S DISEASE AND PARKINSONISM: TRANSCRANIAL SONOGRAPHY

S. Eroglu Durmaz, O. Kursun, N. Oztekin, Y. Sucullu Karadag (Ankara, Turkey)

A direct longitudinal comparison of free water diffusion MRI and DaTscan SPECT in Parkinson’s Disease.

C. Conklin, D. Scott, L. Bracoud, J. Suhy (Princeton, USA)

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA non-manifesting carriers

A. Droby, M. Artzi, H. Lerman, RM. Hutchison, D. Ben Bashat, N. Omer, T. Gurevich, A. Orr-Urtreger, B. Cohen, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

Altered functional activity of the motor system related to ankle and hand movements in Parkinson’s disease: insights from functional MRI

T. Gauss, I. Malik, J. Martello, C. Knight, J. Jeka, R. Burciu (Newark, USA)

Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease

D. Pourzinal, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (Herston, Australia)

Altered glymphatic function in Parkinson’s disease

N. Ryoo, YJ. Bae, YS. Song, JM. Kim (Seongnam-Si, Republic of Korea)

Altered Resting-state Neural Activity in Parkinson’s Disease with Depression: a controlled study based on original meta-analysis results

D. Su, Y. Cheng, J. Zhou, T. Feng (Beijing, China)

An Eyes-Open/Closed Manipulation Reveals Disrupted Default Mode Network Connectivity in Parkinson’s Disease and REM Sleep Behavior Disorder

T. Ellmore, J. Suescun, S. Chandra, V. Thyne, M. Schiess (New York, USA)

Analysis of brain structural connectivity networks and white matter integrity in patients with early Parkinson’s disease: a longitudinal study

R. Walsh, M. Bergamino, A. Stokes (Phoenix, USA)

Association between Hippocampal Subfields, CSF Biomarkers, and Cognition in non-demented Parkinson’s patients

S. Becker, O. Granert, M. Timmers, A. Pilotto, L. van Nueten, B. Roeben, G. Salvadore, W. Galpern, J. Streffer, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

Association of presynaptic dopaminergic denervation with therapeutic effects of globus pallidus deep brain stimulation on freezing of gait in advanced Parkinson’s disease

SH. Lee, MS. Kim, YS. Hwang, SY. Jo, SR. Jeon, SJ. Chung (Seoul, Republic of Korea)

Baseline and six months change in cortical perfusion in a mesenchymal stem cell trial for Parkinson’s disease

M. Schiess, J. Suescun, S. Chandra, V. Thyne, T. Ellmore (Houston, USA)

BASELINE OLFACTION TESTING IN PARKINSON’S DISEASE PATIENTS IS CORRELATED WITH LONG-TERM DOPAMINERGIC DENERVATION IN STRIATAL SUB-REGIONS: LONGITUDINAL DATA FROM THE PPMI STUDY.

C. Koros, A-M. Simitsi, N. Papagiannakis, A. Prentakis, A. Bougea, D. Papadimitriou, R. Antonelou, I. Pachi, E. Angelopoulou, E. Stanitsa, I. Beratis, S. Papageorgiou, M. Stamelou, X. Trapali, L. Stefanis (Athens, Greece)

Brain activity of the emotional circuit in Parkinson’s disease patients with freezing of gait

E. Sarasso, F. Agosta, N. Piramide, E. Canu, MA. Volontè, M. Filippi (Milan, Italy)

Brainstem planimetry in Parkinson’s disease with REM behaviour disorder.

D. Urso, S. Nigro, B. Tafuri, G. Logroscino (Tricase, Italy)

Cerebral white matter atrophy may be associated with the performance of activities of daily livings in patients with Parkinson’s disease

YK. Chen, ZH. Lu, XL. Fu (Dongguan, China)

Changes in brain functional connectivity after cognitive behavioral therapy for anxiety in Parkinson’s disease: a longitudinal MRI study.

G. Carey, R. Lopes, A. Moonen, K. Dujardin, A. Leentjens (Lille, France)

Changes in the cerebellar activity during task based and resting state fMRI in Parkinson’s disease patients with mild cognitive impairment

J. Yang, G. Byrne, K. Mcmahon, D. Copland, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

Characteristics of the amyloid beta networks in Parkinson’s disease patients: a PPMI study

A. Mihascu, M. Valli, M. Diez-Cirarda, Y. Koshimori, J. Kim, A. Strafella (Toronto, Canada)

Clinical and transcranial sonography characteristics in benign phenotype of Parkinson’s disease.

A. Planas-Ballvé, N. Caballol, A. ávila (Barcelona, Spain)

Clinical correlates of Parkinson’s disease metabolic pattern: not only a diagnostic tool

G. Martí-Andrés, R. Valentí, E. Prieto, M. Riverol, MR. Luquin, J. Arbizu (Pamplona, Spain)

Cognition-related functional topographies in Parkinson’s disease: Localized loss of the ventral default mode network

K. Schindlbeck, A. Vo, P. Mattis, K. Villringer, F. Marzinzik, J. Fiebach, D. Eidelberg (Manhasset, USA)

Comorbid Moyamoya Disease and Parkinson’s disease: A case series

D. Yoo (Seoul, Republic of Korea)

Compensatory functional mechanisms of response inhibition in Parkinson’s Disease with impulse control disorders

T. Esteban-Peñalba, P. Paz-Alonso, I. Navalpotro-Gomez, M. Rodriguez-Oroz (Donostia, Spain)

Constipation in Parkinson’s disease: Clinical and Neurosonographic Study

R. Soliman, N. Kishk, M. Oraby, A. Alsayyad, M. Abdelsalam, M. Abosrea (Cairo, Egypt)

Cortical microstructural alterations are more sensitive than morphology changes to cortical degeneration in Parkinson’s disease with mild cognitive impairment

X. Bai, T. Guo, X. Guan, C. Zhou, J. Wu, M. Zhang (Hangzhou, China)

DAT-IQ improves power to detect longitudinal change in DaT deficit in SURE-PD3

Z. Fan, J. Seibyl, K. Marek, M. Schwarzschild, E. Macklin, R. Gunn (London, United Kingdom)

DAT-SPECT in old onset Parkinson’s disease: should we trust?

G. Palermo, S. Giannoni, D. Frosini, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

Deep learning based detection of Parkinson’s disease (PD) in Magnetic Resonance Imaging (MRI) brain scans

M. Courtman, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)

Developing 31-phosphorus magnetic resonance spectroscopy (31P-MRS) as an imaging biomarker to identify mitochondrial dysfunction in Parkinson’s disease

T. Payne, M. Sassani, S. Roscoe, S. Bradley, A. Anton, E. Reed, I. Wilkinson, H. Mortiboys, T. Jenkins, O. Bandmann (Sheffield, United Kingdom)

Dissociated longitudinal evolution of limbic serotonergic and striatal dopaminergic and serotonergic pathology in apathetic and non-apathetic patients in early Parkinson’s disease

S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

Distinct cholinergic reactivity to dopamine is related with differed parkinsonian tremor responsiveness

J. Wu, C. Zhou, T. Guo, X. Guan, X. Bai, H. Wu, J. Chen, J. Wen, X. Liu, P. Huang, X. Xu, M. Zhang (Hangzhou, China)

Distinct memory networks in Parkinson’s disease (PD) and Alzheimer’s disease (AD): Effects of APOE

G. Coughlan, P. Mclaughlin, K. Sunderland, M. Borrie, C. Fischer, A. Frank, M. Freedman, S. Kumar, S. Pasternak, B. Pollock, T. Rajji, D. Seitz, D. Tang-Wai, C. Tartaglia, J. Dewar, D. Kwan, B. Tan, D. Grimes, M. Jog, T. Lang, C. Marras, T. Steeves, D. Bulman, A. Dilliott, M. Ghani, R. Hegele, J. Robinson, E. Rogaeva, S. Farhan, R. Bartha, N. Nanayakkara, J. Ramirez, C. Scott, S. Symons, C. Berezuk, M. Holmes, S. Adamo, M. Ozzoude, A. Theyers, S. Arnott, D. Beaton, W. Lou, S. Sujanthan, B. Levine, J. Orange, A. Peltsch, A. Roberts, A. Troyer, M. Binns, S. Black, S. Strother, M. Moscovitch, C. Grady, M. Masellis (Toronto, Canada)

DO FREEZING OF GAIT AND GAIT AUTOMATICITY IN PARKINSON’S DISEASE SHARE THE SIMILAR NEURAL SUBSTRATE?

F. de Almeida, C. Ugrinowitsch, M. Nucci, D. Coelho, A. Moreira-Neto, E. Barbosa, L. Teixeira, E. Amaro JR., F. Horak, M. Mancini, C. Silva-Batista (São Paulo, Brazil)

Does neurodegeneration of the noradrenergic locus coeruleus follow a spatial gradient in Parkinson’s disease?

C. Madelung, D. Meder, S. Fuglsang, V. Boer, E. Petersen, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)

Dynamic functional connectivity changes in Parkinson’s disease patients with REM sleep behavior disorder

C. Gan, K. Zhang, Y. Yuan (Nanjing, China)

Dysfunctional resting connectivity in early stage of Parkinson’s disease is indistinguishable from connectivity in REM sleep behaviour disorder

P. štofaniková, F. Růžička, K. Mueller, T. Ballarini, E. Růžička, K. šonka, P. Dušek, R. Jech (Prague, Czech Republic)

EVALUATION OF THE ABSENCE OF NIGROSOME 1 BY MAGNETIC RESONANCE 3 TESLA IN PARKINSON’S DISEASE ACCORDING TO TIME OF EVOLUTION TO DIAGNOSIS VS MESENCEPHALIC ECOGRAPHY.

J. Bestoso, L. Ciancaglini, C. Stefani, F. Silveira, M. Pérez Akly, J. Norscini, J. Funes, C. Besada, D. Bauso (Buenos Aires, Argentina)

EVOLUTION OF PARKINSON’S DISEASE IN PATIENTS WITH ESSENTIAL TREMOR: CLINICAL AND NEUROIMAGING ASPECTS

G. Froehner, C. Camargo, G. Fabiani, A. Meira, H. Teive (Curitiba, Brazil)

Factors contributing to prefrontal cortical activity during walking and its response to dual-tasking in Parkinson’s disease

R. Vitorio, S. Stuart, M. Mancini (Portland, USA)

Feasibility study of diffusion tensor imaging fiber tracking in PD patients after DBS operation

Y. Li, C. Zhang, N. He, F. Yan, E. Haacke (Shanghai, China)

Functional connectivity as an early marker of indication for deep brain stimulation treatment in Parkinson’s disease (PD)

L. Albano, F. Agosta, S. Basaia, C. Cividini, T. Stojkovic, E. Sarasso, I. Stankovic, A. Tomic, V. Markovic, E. Stefanova, P. Mortini, V. Kostic, M. Filippi (Milan, Italy)

Impaired interhemispheric synchrony in Parkinson’s disease patients with impulse control disorders

C. Gan, K. Zhang, Y. Yuan (Nanjing, China)

In-vivo cholinergic basal forebrain degeneration and cognition in Parkinson’s disease: imaging results from the COPPADIS study

MJ. Grothe, MA. Labrador-Espinosa, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, E. Iglesias Camacho, P. Franco-Rosado, F. Roldán Lora, JF. Martín-Rodríguez, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, J. Kulisevsky, P. Martínez-Martín, D. Santos-García, P. Mir (Seville, Spain)

Increased free-water in the substantia nigra in idiopathic REM sleep behaviour disorder

L. Zhou, G. Li, Y. Zhang, B. Li, H. Wei, J. Liu (Shanghai, China)

Insulin resistance and Parkinson’s disease

E. Hogg, H. Maghzi, P. Mcelhinney, E. Tan, T. Wu, H. Pomeroy, D. Dey, G. Pagano, M. Tagliati (Los Angeles, USA)

Interest of optical coherence tomography in Parkinson’s disease

N. Chtaou, S. Bouchal, A. El Midaoui, Z. Souirti, M F. Belahsen, M. Bouhlal (Fez, Morocco)

Intrasubject subcortical quantitative referencing to make quantitative MRI sensitive to Parkinson’s disease

L. Khedher, JM. Bonny, F. Durif (Clermont Ferrand, France)

Locus coeruleus degeneration associated with less levodopa responsiveness in Parkinson’s Disease

C. Zhou, B. Zhang, M. Zhang (Hangzhou, China)

Longitudinal change in thalamic white matter macrostructure and volume in Parkinson’s disease depression

R. Bhome, A. Zarkali, J. Cole, R. Weil (London, United Kingdom)

Longitudinal changes in nigral neuromelanin in early, levodopa-treated Parkinson’s disease

K. Hwang, J. Langley, N. Kurra, S. Factor, X. Hu, D. Huddleston (Atlanta, USA)

Longitudinal structural and functional brain alterations in Parkinson’s disease patients with freezing of gait

N. Piramide, F. Agosta, E. Sarasso, T. Stojkovic, I. Stankovic, S. Basaia, A. Tomic, V. Markovic, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

Longitudinal Study of Grey Matter Nuclei in Early Parkinson’s Disease using Diffusion Kurtosis Imaging

T. Welton, S. Hartono, Y-C. Shih, W. Lee, SL. Chong, S. Ng, N. Chia, EK. Tan, LL. Chan, L. Tan (Singapore, Singapore)

Motor cerebro-cerebellar networks breakdown among different subtypes of Parkinson’s disease

S. Basaia, F. Agosta, A. Francia, C. Cividini, T. Stojkovic, I. Stankovic, R. de Micco, L. Albano, E. Sarasso, A. Gardoni, N. Piramide, V. Markovic, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

Motor symptom lateralization influences cortico-striatal functional connectivity in Parkinson’s disease

W. Su, K. Li, C. Li, X. Ma, H. Zhao, M. Chen, S. Li, R. Wang, B. Lou, H. Chen, C. Yan (Jinan, China)

Movement-related dynamics of β-γ phase-amplitude coupling in repetitive movement tasks of Parkinson disease

R. Gong, T. Knösche, J. Classen (Leipzig, Germany)

Neuroanatomical signatures of genetic risk for Parkinson’s Disease in healthy adults

S. Waters, J. Kim, C. Watson, B. Jacobs, I. Foote, S. Dey, C. Blauwendraat, A. Noyce, C. Marshall (London, United Kingdom)

Neurofilament light is related to fractional anisotropy in early Parkinson’s diesease

T. Welton, Y. Tan, S. Saffari, N. Chia, S. Ng, Z. Lu, A. Yong, X. Choi, D. Heng, YC. Shih, S. Hartono, W. Lee, Z. Xu, K. Tay, WL. Au, EK. Tan, LL. Chan, A. Ng, L. Tan (Singapore, Singapore)

Neurogenetic Traits Outline Vulnerability to Cortical Disruption in Parkinson’s Disease

S. Basaia, F. Agosta, I. Diez Palacio, E. Bueichekú, F. D’Oleire Uquillas, M. Delgado-Alvarado, C. Caballero-Gaudes, M. Rodriguez-Oroz, T. Stojkovic, V. Kostic, M. Filippi, J. Sepulcre (Milan, Italy)

Normal-sized Perivascular Space in Basal Ganglia Related to Motor Phenotypes in Parkinson Freezers

Y. Yue, W. Lv, T. Shen, XY. Hu, H. Lai, F. Ba (Hangzhou, China)

Paradoxical cerebral hyperperfusion in Parkinson’s disease with orthostatic hypotension

S-W. Yoo, J-S. Kim, K-S. Lee, S. Ha (Seoul, Republic of Korea)

Parkinson Disease with, but not without, Cognitive Decline Reveals Advanced Brain Aging

MC. Kuo, CL. Chen, RM. Wu, WY. Tseng (Taipei, Taiwan)

Patterns of Cortical Thinning in Patients with Parkinson’s Disease

H. Jergas, JC. Baldermann, JN. Petry-Schmelzer, H. Dafsari, V. Visser-Vanderwalle, T. Dembek, M. Barbe (Cologne, Germany)

Perivascular spaces in the basal ganglia and long-term motor prognosis in newly diagnosed Parkinson’s disease

SJ. Chung, YJ. Kim, PH. Lee, YH. Sohn (Yongin-Si, Republic of Korea)

Progression of brain atrophy in Parkinson’s disease is shaped by connectome and local vulnerability

C. Tremblay, S. Rahayel, A. Vo, F. Morys, G. Shafiei, R. Markello, Z. Gan-Or, B. Misic, A. Dagher (Montreal, Canada)

Progression of nigrostriatal dysfunction in Parkinson’s disease: a longitudinal multimodal PET study

K. Steidel, M. Ruppert, A. Greuel, M. Tahmasian, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, D. Pedrosa, C. Eggers (Marburg, Germany)

Progressive changes in laryngeal posturing and dynamics as biomarkers of progression in Parkinson’s disease

A. Ma, D. Thyagarajan, K. Lau (Melbourne, Australia)

Reduced cerebral energy metabolism in Parkinson’s disease in contrast to Progressive Supranuclear Palsy

J. Prasuhn, M. Göttlich, B. Ebeling, S. Kourou, F. Gerkan, C. Bodemann, S. Großer, K. Reuther, H. Hanssen, N. Brüggemann (Lübeck, Germany)

Regional brain iron and gene expression variation in Parkinson’s disease

G. Thomas, A. Zarkali, M. Ryten, K. Shmueli, AL. Gil Martinez, LA. Leyland, P. Mccolgan, J. Acosta-Cabronero, A. Lees, R. Weil (London, United Kingdom)

Relationship Between Hyposmia and Olfactory Network Connectivity in Patients With Parkinson’s Disease

L. Pesantez Pacheco, S. Horovitz (Bethesda, USA)

Relationship of subcortical iron deposition and mitochondrial dysfunction in patients with idiopathic Parkinson’s disease

J. Prasuhn, M. Göttlich, F. Gerkan, S. Kourou, B. Ebeling, M. Kasten, H. Hanssen, C. Klein, N. Brüggemann (Lübeck, Germany)